Concord Drugs Ltd Share Price & Stock Analysis

Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products; ready-to-fill pellets and multiple unit pellets system; other drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. The company was incorporated in 1995 and is based in Hyderabad, India.

Key Metrics

Current Price	₹80.10
Market Cap	₹106 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Pharmaceutical Products
P/E Ratio	84.3
Return on Equity	2.55%
Beta (1Y)	0.42

Business Segments

1. Pharmaceutical Products-100%

Peer Companies

• Abbott India Ltd.
• Ajanta Pharma Limited
• Astrazeneca Pharma India Ltd.
• Pfizer Ltd.
• Eris Lifesciences Ltd
• Caplin Point Laboratories Ltdte
• Marksans Pharma Ltd.
• Strides Pharma Science Limited (Star)

Frequently Asked Questions

What is the current share price of Concord Drugs Ltd?

Concord Drugs Ltd is trading at ₹80.10, with a market capitalisation of ₹106 Cr.

Which sector does Concord Drugs Ltd belong to?

Concord Drugs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).

What are the key financial ratios of Concord Drugs Ltd?

Concord Drugs Ltd has a P/E of 84.3 and a return on equity of 2.55%.